• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket

    6/16/23 8:10:56 AM ET
    $AUVI
    $CELZ
    $CLNN
    $COHN
    Building Products
    Consumer Discretionary
    Finance: Consumer Services
    Finance
    Get the next $AUVI alert in real time by email

    Gainers

    • Evelo Biosciences, Inc. (NASDAQ:EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #11672834 for "Prebiotic Compositions And Methods Of Use Thereof For Modulation Of The Microbiome."
    • Plutonian Acquisition Corp. (NASDAQ:PLTNR) shares surged 42.4% to $0.47 in pre-market trading after jumping 32% on Thursday.
    • Humanigen, Inc. (NASDAQ:HGEN) shares rose 39.2% to $0.2227 in pre-market trading. Humanigen recently presented promising new hematologic data from PREACH-M trial for chronic myelomonocytic leukemia treatment at the 2023 European Hematology Association Congress.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) shares rose 38.7% to $5.63 in pre-market trading as the company announced the start of commercial spaceline operations. The company said its first commercial spaceflight, "Galactic 01," is set to fly between June 27 and June 30.
    • COMSovereign Holding Corp. (NASDAQ:COMS) gained 26.4% to $2.34 in pre-market trading.
    • Nikola Corporation (NASDAQ:NKLA) gained 24.3% to $1.74 in pre-market trading after gaining around 30% on Thursday. The EV maker also gained last week after shareholders reportedly rejected the company's proposal to issue more stock shares.
    • FingerMotion, Inc. (NASDAQ:FNGR) shares gained 23.2% to $2.50 in pre-market trading after climbing over 18% on Thursday.
    • Cohen & Company Inc. (NYSE:COHN) rose 20.8% to $5.45 in pre-market trading.
    • OpGen, Inc. (NASDAQ:OPGN) shares climbed 16.9% to $0.7133 in pre-market trading. OpGen, last month, posted a wider-than-expected quarterly loss.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) rose 9.2% to $0.1960 in pre-market trading. MEI Pharma and Infinity Pharmaceuticals, said that the companies will host a recorded joint video webcast that will be available at 8:00 am Eastern Time on June 19, 2023.

    Losers

    • Applied UV, Inc. (NASDAQ:AUVI) fell 33.2% to $1.27 in pre-market. Applied UV retained Quantiva to integrate AI and machine learning capabilities into its PURONetaAnd Airocide Systems.
    • Clene Inc. (NASDAQ:CLNN) fell 20.1% to $0.8399 in pre-market trading after the company reported the launch of proposed public offering. Clene’s CNM-Au8 treatment demonstrated a statistically significant reduction of plasma neurofilament light chain levels compared to placebo at 24 weeks.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) fell 15.3% to $4.80 in pre-market trading after jumping around 25% on Thursday. The company recently reported a $2 million buyback program.
    • SCWorx Corp. (NASDAQ:WORX) fell 14.3% to $0.3209 in pre-market trading after gaining over 70% on Thursday.
    • EdtechX Holdings Acquisition Corp. II (NASDAQ:EDTX) shares dropped 13.5% to $29.39 in pre-market trading after jumping 207% on Thursday. The company announced Wednesday an amendment to extend the date to consummate a business combination from June 15, 2023 to Dec. 15, 2023.
    • Leju Holdings Limited (NYSE:LEJU) shares dropped 11.5% to $3.39 in pre-market trading after gaining 31% on Thursday.
    • VIQ Solutions Inc. (NASDAQ:VQS) shares fell 10.5% to $0.3111 in pre-market trading. VIQ Solutions shares gained 32% on Thursday after the company partnered Justice AV Solutions to bring AI-generated draft transcripts of courtroom proceedings.
    • Tenon Medical, Inc. (NASDAQ:TNON) fell 10.5% to $0.3031 in pre-market trading after adding 16% on Thursday. Tenon Medical recently priced its public offering of $5.6M at $0.56 per unit.
    • Verastem, Inc. (NASDAQ:VSTM) fell 10.3% to $9.70 in pre-market trading after the company reported a proposed public offering of common stock and pre-funded warrants.
    • Planet Green Holdings Corp. (NYSE:PLAG) fell 10.1% to $0.8995 in pre-market trading after surging around 33% on Thursday.

     

    Now Read This: Investor Sentiment Improves Further After Dow Jumps Over 400 Points

    Get the next $AUVI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AUVI
    $CELZ
    $CLNN
    $COHN

    CompanyDatePrice TargetRatingAnalyst
    Verastem Inc.
    $VSTM
    3/12/2026$19.00Buy
    BTIG Research
    Verastem Inc.
    $VSTM
    2/4/2026$18.00Buy
    H.C. Wainwright
    Verastem Inc.
    $VSTM
    10/16/2025Overweight
    Cantor Fitzgerald
    Virgin Galactic Holdings Inc.
    $SPCE
    6/30/2025$3.00Neutral
    Goldman
    Verastem Inc.
    $VSTM
    4/10/2025$15.00Buy
    Jefferies
    Verastem Inc.
    $VSTM
    3/24/2025$7.00 → $10.00Buy
    H.C. Wainwright
    Verastem Inc.
    $VSTM
    12/31/2024$13.00 → $20.00Buy
    BTIG Research
    Nikola Corporation
    $NKLA
    11/7/2024Buy → Neutral
    Bryan Garnier
    More analyst ratings

    $AUVI
    $CELZ
    $CLNN
    $COHN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research resumed coverage on Verastem with a new price target

    BTIG Research resumed coverage of Verastem with a rating of Buy and set a new price target of $19.00

    3/12/26 8:55:19 AM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    H.C. Wainwright initiated coverage on Verastem with a new price target

    H.C. Wainwright initiated coverage of Verastem with a rating of Buy and set a new price target of $18.00

    2/4/26 8:31:21 AM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald resumed coverage on Verastem

    Cantor Fitzgerald resumed coverage of Verastem with a rating of Overweight

    10/16/25 8:50:56 AM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUVI
    $CELZ
    $CLNN
    $COHN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Cohen Daniel G gifted 8,000 shares, decreasing direct ownership by 24% to 24,757 units (SEC Form 4)

    4 - Cohen & Co Inc. (0001270436) (Issuer)

    4/24/26 11:14:49 AM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by Shen Martin Chung-Wen

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    4/23/26 9:16:36 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Ugwumba Chidozie

    4 - Clene Inc. (0001822791) (Issuer)

    4/22/26 5:55:36 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AUVI
    $CELZ
    $CLNN
    $COHN
    SEC Filings

    View All

    Amendment: SEC Form 10-K/A filed by Creative Medical Technology Holdings Inc.

    10-K/A - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (0001187953) (Filer)

    4/24/26 4:45:24 PM ET
    $CELZ
    Finance: Consumer Services
    Finance

    SEC Form 8-K filed by Virgin Galactic Holdings Inc.

    8-K - Virgin Galactic Holdings, Inc (0001706946) (Filer)

    4/24/26 4:06:50 PM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    SEC Form DEFA14A filed by Virgin Galactic Holdings Inc.

    DEFA14A - Virgin Galactic Holdings, Inc (0001706946) (Filer)

    4/21/26 4:48:43 PM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    $AUVI
    $CELZ
    $CLNN
    $COHN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    Director Leong Yew Poh decreased direct ownership by 6% to 170,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/8/25 7:08:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $AUVI
    $CELZ
    $CLNN
    $COHN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026

    Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the Company will host a conference call and webcast to discuss its first quarter 2026 financial results and business updates on Thursday, May 7, 2026, at 4:30 pm ET. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, https://investor.verastem.com/events. A replay of the webcast will be archived and available following the event. About Verastem Oncology Verastem Oncology (NASDAQ:VSTM) is a biopharmaceutical

    4/23/26 7:30:00 AM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SCWorx Announces Two New Customer Wins Through Strategic Partner Channel

    New York, NY, April 22, 2026 (GLOBE NEWSWIRE) -- SCWorx Corp. ("SCWorx" or the "Company"), a leading provider of data management, analytics, and supply chain solutions for the healthcare industry, today announced that it has secured two new customers through a strategic partner relationship. Both customers are currently engaged in preparatory data initiatives in advance of planned ERP implementations. The new engagements underscore SCWorx's growing role as a critical data readiness and normalization partner in enterprise system transformations. Each customer will leverage SCWorx's platform to standardize, cleanse, and structure key operational and financial data sets required for success

    4/22/26 10:28:56 AM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Virgin Galactic Reports Inducement Award Under NYSE Listing Rule 303A.08

    Virgin Galactic Holdings, Inc. (NYSE:SPCE) ("Virgin Galactic") announced that the Compensation Committee of Virgin Galactic's Board of Directors approved the grants of time-based inducement restricted stock units ("RSUs") covering an aggregate of 484,793 shares of Virgin Galactic common stock and performance-vesting restricted stock units ("PSUs") awards (collectively, the "Awards") covering an aggregate of 384,793 shares of Virgin Galactic common stock to a new non-executive employee, effective April 15, 2026. The awards were granted under Virgin Galactic's Second Amended and Restated 2023 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new

    4/20/26 6:45:00 AM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    $AUVI
    $CELZ
    $CLNN
    $COHN
    Financials

    Live finance-specific insights

    View All

    Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026

    Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the Company will host a conference call and webcast to discuss its first quarter 2026 financial results and business updates on Thursday, May 7, 2026, at 4:30 pm ET. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, https://investor.verastem.com/events. A replay of the webcast will be archived and available following the event. About Verastem Oncology Verastem Oncology (NASDAQ:VSTM) is a biopharmaceutical

    4/23/26 7:30:00 AM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Virgin Galactic Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    Sales Open for Virgin Galactic Spaceflight Expeditions - Priced At $750K First of Two New SpaceShips Progressing to Ground Test Phase in April; Flight Test Phase Begins Q3 2026 Commercial Spaceflight Operations with First New SpaceShip Continue on Track for Q4 2026 Second New SpaceShip Expected to Enter Service Between Late Q4 2026 and Early Q1 2027 Virgin Galactic Holdings, Inc. (NYSE:SPCE) ("Virgin Galactic" or the "Company") today announced its financial results for the fourth quarter and full year ended December 31, 2025 and provided a business update. CEO Michael Colglazier said, "We completed pivotal milestones during the first quarter of 2026, and with assembly of our

    3/30/26 4:05:00 PM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    Cohen & Company Reports Fourth Quarter & Full Year 2025 Financial Results

    Board Declares Quarterly Dividend of $0.25 per Share and Special Dividend of $0.70 per Share Revenue of $102.7 Million in Fourth Quarter 2025 and $275.6 Million in Full Year 2025 Net Income Attributable to Cohen & Company Inc. of $8.1 Million, or $1.48 per Diluted Share, in Fourth Quarter 2025 and $14.4 Million, or $4.35 per Diluted Share, in Full Year 2025 Adjusted Pre-Tax Income of $18.3 Million, or $2.97 per Diluted Share, in Fourth Quarter 2025 and $41.4 Million, or $6.92 per Diluted Share, in Full Year 2025 PHILADELPHIA and NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Cohen & Company Inc. (NYSE:COHN) today reported financial results for its fourth quarter and full year ended Decem

    3/6/26 8:00:00 AM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance

    $AUVI
    $CELZ
    $CLNN
    $COHN
    Leadership Updates

    Live Leadership Updates

    View All

    Virgin Galactic Appoints Megan Prichard as Chief Growth Officer

    Veteran technology leader and former Uber executive to drive revenue growth, market expansion and customer acquisition for human spaceflight and research missions Virgin Galactic Holdings, Inc. (NYSE:SPCE) ("Virgin Galactic" or the "Company"), a leader in commercial spaceflight and advanced aerospace technology, today announced the appointment of Megan Prichard as its new Chief Growth Officer (CGO), effective April 6. In this newly established role, Prichard will lead the Company's integrated growth and revenue strategy across all business lines while strengthening Virgin Galactic's position as the premier platform for suborbital spaceflight expeditions and scientific research. Prichard

    3/23/26 4:05:00 PM ET
    $BL
    $SPCE
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    Cohen & Company Announces Appointment of Pawel Skonieczka as Managing Director to Lead Coverage of Space Technology, Aerospace, & Communications Infrastructure in Capital Markets Segment

    NEW YORK, Feb. 26, 2026 /PRNewswire/ -- After nearly doubling deal flow and closing $43 billion in transactions in 2025, Cohen & Company Capital Markets ("CCM"), a division of Cohen & Company Securities, LLC, an indirect, controlled subsidiary of Cohen & Company Inc. (NYSE:COHN), announced the appointment of Pawel Skonieczka as a Managing Director to lead the expansion of the firm's advisory capabilities across Space Technology, Aerospace, and Communications Infrastructure. Mr. Skonieczka brings nearly two decades of experience advising public and private companies, financial sp

    2/26/26 10:43:00 AM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance

    Cohen & Company Announces Appointment of Senior Leadership to Expand Energy and Energy Transition Capabilities

    Firm Launches Houston Office Strategic Hire Anchors Firm's Expansion Across Energy, Power, and Infrastructure PHILADELPHIA and NEW YORK, Jan. 12, 2026 /PRNewswire/ -- After nearly doubling deal flow and closing $44 billion in transactions in 2025, Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, an indirect, controlled subsidiary of Cohen & Company Inc. (NYSE:COHN), today announced the appointment of senior leadership to its Energy and Energy Transition team, along with the opening of its Houston office to serve as the firm's hub for energy and energy transition advisory services.

    1/12/26 8:00:00 AM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance

    $AUVI
    $CELZ
    $CLNN
    $COHN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by SCWorx Corp.

    SC 13G - SCWorx Corp. (0001674227) (Subject)

    12/5/24 7:17:43 AM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Cohen & Company Inc.

    SC 13D/A - Cohen & Co Inc. (0001270436) (Subject)

    12/3/24 4:18:04 PM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance

    Amendment: SEC Form SC 13D/A filed by Cohen & Company Inc.

    SC 13D/A - Cohen & Co Inc. (0001270436) (Subject)

    12/3/24 4:17:31 PM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance